Attenuated Psychosis Syndrome
Resources for Patients and Caregivers
The DSM-5 has listed attenuated psychosis syndrome (APS) as a “condition for future study.” APS can involve mild delusions, hallucinations, and disorganized speech, with relatively intact reality testing in the absence of a clear psychotic disorder, and has been thought to be a risk state for later schizophrenia
Wiki Number: 07-Attenuated Psychosis Syndrome
Diagnosis: Lower levels of psychotic symptoms-such as low-intensity hallucinations
Youtube Video: The 3 Traits of Psychosis
Amazon or Library Book:
Handbook of Attenuated Psychosis Syndrome Across Cultures
Click the book to link or order from Amazon.
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Attenuated niacin response is associated with a subtype of first-episode drug-naïve psychosis characterized as serious negative symptomsby TianHong Zhang on January 23, 2023
Although the phenomenon of attenuated niacin response (ANR) has been widely replicated in some patients with first-episode psychosis (FEP), its relevance to the negative symptoms (NS) of psychosis remains unclear. Total of 240 patients with drug-naïve FEP and 101 healthy controls (HCs) were recruited, and 209 were followed up for 1 year. Psychotic symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and niacin-induced responses were measured using laser Doppler...
- The effects of the COVID-19 pandemic on hallucinations and delusions in youth at clinical high-risk for psychosis and outpatients with schizophreniaby Alysia M Berglund on January 21, 2023
Although the COVID-19 pandemic has had detrimental effects on mental health in the general population, the impact on those with schizophrenia-spectrum disorders has received relatively little attention. Assessing pandemic-related changes in positive symptoms is particularly critical to inform treatment protocols and determine whether fluctuations in hallucinations and delusions are related to telehealth utilization and treatment adherence. In the current longitudinal study, we evaluated changes...
- Cognitive predictors of transition and remission of psychosis risk syndrome in a child and adolescent sample: longitudinal findings from the CAPRIS studyby Jordina Tor on January 4, 2023
Cognitive impairments are proposed as predictors in the differentiation between subjects with psychosis risk syndrome (PRS) who will develop a psychotic disorder (PRS-P) and those who will not (PRS-NP). More in-depth study of the PRS-NP group could contribute to defining the role of cognitive alterations in psychosis. This study aims to analyze cognition of children and adolescents with PRS in terms of their clinical outcome at 18-month follow-up (psychosis, remission, and non-remission) and of...
- The Mini-SIPS: development of a brief clinical structured interview guide to diagnosing DSM-5 Attenuated Psychosis Syndrome and training outcomesby Scott W Woods on December 13, 2022
CONCLUSION: The Mini-SIPS, and accompanying training program, are offered as public-domain clinical resources to the mental health community.